| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
NextCure Inc (NASDAQ: NXTC)
NXTC Technical Analysis
5
| As on 9th Jun 2023 NXTC STOCK Price closed @ 1.66 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 4.28 & Strong Sell for SHORT-TERM with Stoploss of 5.40 we also expect STOCK to react on Following IMPORTANT LEVELS. |
NXTCSTOCK Price
| Open | 1.79 | Change | Price | % |
| High | 1.79 | 1 Day | -0.11 | -6.21 |
| Low | 1.66 | 1 Week | -0.06 | -3.49 |
| Close | 1.66 | 1 Month | 0.15 | 9.93 |
| Volume | 9600 | 1 Year | -4.11 | -71.23 |
| 52 Week High 6.24 | 52 Week Low 1.20 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| NXTC Daily Charts |
NXTC Intraday Charts |
Whats New @ Bazaartrend |
NXTC Free Analysis |
|
|
NXTC Important Levels Intraday
| RESISTANCE | 1.91 |
| RESISTANCE | 1.83 |
| RESISTANCE | 1.78 |
| RESISTANCE | 1.73 |
| SUPPORT | 1.59 |
| SUPPORT | 1.54 |
| SUPPORT | 1.49 |
| SUPPORT | 1.41 |
NXTC Forecast May 2024
| 4th UP Forecast | 3.47 |
| 3rd UP Forecast | 2.89 |
| 2nd UP Forecast | 2.53 |
| 1st UP Forecast | 2.17 |
| 1st DOWN Forecast | 1.15 |
| 2nd DOWN Forecast | 0.79 |
| 3rd DOWN Forecast | 0.43 |
| 4th DOWN Forecast | -0.15 |
NXTC Weekly Forecast
| 4th UP Forecast | 2.85 |
| 3rd UP Forecast | 2.47 |
| 2nd UP Forecast | 2.23 |
| 1st UP Forecast | 2.00 |
| 1st DOWN Forecast | 1.32 |
| 2nd DOWN Forecast | 1.09 |
| 3rd DOWN Forecast | 0.85 |
| 4th DOWN Forecast | 0.47 |
NXTC Forecast2024
| 4th UP Forecast | 11.91 |
| 3rd UP Forecast | 8.62 |
| 2nd UP Forecast | 6.59 |
| 1st UP Forecast | 4.56 |
| 1st DOWN Forecast | -1.24 |
| 2nd DOWN Forecast | -3.27 |
| 3rd DOWN Forecast | -5.3 |
| 4th DOWN Forecast | -8.59 |
NextCure Inc ( NASDAQ USA Symbol : NXTC )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
NXTC Business Profile
NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines to treat cancer and other immune-related diseases by restoring normal immune function. Its lead product candidate is NC318, which is in Phase II clinical trials for the treatment of advanced or metastatic solid tumors. The company is also developing NC410, which is in Phase I for novel immunomedicine designed to block immune suppression mediated by an immune modulator called Leukocyte-Associated Immunoglobulin-like Receptor 1; and NC762, an immunomedicine targeting a molecule called human B7 homolog 4 protein, or B7-H4. Its discovery and research programs include an antibody in preclinical evaluation of other potential novel immunomodulatory molecules. NextCure, Inc. has a license agreement with Yale University. The company was incorporated in 2015 and is headquartered in Beltsville, Maryland. Address: 9000 Virginia Manor Road, Beltsville, MD, United States, 20705
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service